Have a personal or library account? Click to login
Tremor in Spinocerebellar Ataxia: A Scoping Review Cover

Tremor in Spinocerebellar Ataxia: A Scoping Review

Open Access
|Jun 2024

References

  1. 1Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019 Feb; 266(2): 533544. DOI: 10.1007/s00415-018-9076-4
  2. 2Coarelli G, Coutelier M, Durr A. Autosomal dominant cerebellar ataxias: new genes and progress towards treatments. Lancet Neurol. 2023 Aug; 22(8): 735749. DOI: 10.1016/S1474-4422(23)00068-6.
  3. 3Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019 Apr 11; 5(1): 24. DOI: 10.1038/s41572-019-0074-3
  4. 4Magrinelli F, Latorre A, Balint B, et al. Isolated and combined genetic tremor syndromes: a critical appraisal based on the 2018 MDS criteria. Parkinsonism Relat Disord. 2020 Aug; 77: 121140. DOI: 10.1016/j.parkreldis.2020.04.010
  5. 5Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the ‘the Drew family of Walworth’. Brain. 1982 Mar; 105(Pt 1): 128. DOI: 10.1093/brain/105.1.1
  6. 6Lai RY, Tomishon D, Figueroa KP, et al. Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. Cerebellum. 2019 Jun; 18(3): 519526. DOI: 10.1007/s12311-019-01016-6
  7. 7Lee WY, Jin DK, Oh MR, et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol. 2003 Jun; 60(6): 85863. DOI: 10.1001/archneur.60.6.858
  8. 8Rüb U, Bürk K, Timmann D, et al. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights. Neuropathol Appl Neurobiol. 2012 Dec; 38(7): 66580. DOI: 10.1111/j.1365-2990.2012.01259.x
  9. 9Schmitz-Hübsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008 Sep 23; 71(13): 9829. DOI: 10.1212/01.wnl.0000325057.33666.72
  10. 10Genis D, Matilla T, Volpini V, et al. Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology. 1995 Jan; 45(1): 2430. DOI: 10.1212/wnl.45.1.24
  11. 11Gan SR, Wang J, Figueroa KP, et al. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2017 Oct 9; 7: 492. DOI: 10.5334/tohm.346
  12. 12Sonakar AK, Shamim U, Srivastava MP, Faruq M, Srivastava AK. SCA2 in the Indian population: Unified haplotype and variable phenotypic patterns in a large case series. Parkinsonism Relat Disord. 2021 Aug; 89: 139145. DOI: 10.1016/j.parkreldis.2021.07.011
  13. 13Schöls L, Peters S, Szymanski S, et al. Extrapyramidal motor signs in degenerative ataxias. Arch Neurol. 2000 Oct; 57(10): 1495500. DOI: 10.1001/archneur.57.10.1495
  14. 14Balakrishnan S, Aggarwal S, Muthulakshmi M, et al. Clinical and Molecular Spectrum of Degenerative Cerebellar Ataxia: A Single Centre Study. Neurol India. 2022 May–Jun; 70(3): 934942. DOI: 10.4103/0028-3886.349660
  15. 15Mizushima K, Watanabe M, Abe K, et al. Analysis of spinocerebellar ataxia type 2 in Gunma Prefecture in Japan: CAG trinucleotide expansion and clinical characteristics. J Neurol Sci. 1998 Apr 1; 156(2): 1805. DOI: 10.1016/s0022-510x(98)00040-9
  16. 16Filla A, De Michele G, Santoro L, et al. Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol. 1999 Jun; 246(6): 46771. DOI: 10.1007/s004150050385
  17. 17Stezin A, Venkatesh SD, Thennarasu K, et al. Non-ataxic manifestations of Spinocerebellar ataxia-2, their determinants and predictors. J Neurol Sci. 2018 Nov 15; 394: 1418. DOI: 10.1016/j.jns.2018.08.024
  18. 18Jhunjhunwala K, Netravathi M, Purushottam M, Jain S, Pal PK. Profile of extrapyramidal manifestations in 85 patients with spinocerebellar ataxia type 1, 2 and 3. J Clin Neurosci. 2014 Jun; 21(6): 10026. DOI: 10.1016/j.jocn.2013.10.021
  19. 19Radhakrishnan DM, Goyal V, Srivastava AK, Shukla G, Behari M. Evaluation of Various Movement Disorders in Patients of Genetically Proven Spinocerebellar Ataxia: A Study from a Tertiary Care Center in Northern India. Ann Indian Acad Neurol. 2018 Jan–Mar; 21(1): 2428. DOI: 10.4103/aian.AIAN_266_17
  20. 20Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Teive HA. Movement disorders in spinocerebellar ataxias in a cohort of Brazilian patients. Eur Neurol. 2014; 72(5–6): 3602. DOI: 10.1159/000365285
  21. 21Schöls L, Gispert S, Vorgerd M, et al. Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds. Arch Neurol. 1997 Sep; 54(9): 107380. DOI: 10.1001/archneur.1997.00550210011007
  22. 22Cancel G, Dürr A, Didierjean O, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet. 1997 May; 6(5): 70915. DOI: 10.1093/hmg/6.5.709
  23. 23Garcia Ruiz PJ, Mayo D, Hernandez J, Cantarero S, Ayuso C. Movement disorders in hereditary ataxias. J Neurol Sci. 2002 Oct 15; 202(1–2): 5964. DOI: 10.1016/s0022-510x(02)00211-3
  24. 24Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997 Apr; 60(4): 84250
  25. 25Sun H, Satake W, Zhang C, et al. Genetic and clinical analysis in a Chinese parkinsonism-predominant spinocerebellar ataxia type 2 family. J Hum Genet. 2011 Apr; 56(4): 3304. DOI: 10.1038/jhg.2011.14
  26. 26Pirker W, Back C, Gerschlager W, Laccone F, Alesch F. Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2. Mov Disord. 2003 Feb; 18(2): 2225. DOI: 10.1002/mds.10192
  27. 27Isobe T, Sato H, Goto T, Yako T, Yoshida K, Hashimoto T. Long-Term Suppression of Disabling Tremor by Thalamic Stimulation in a Patient with Spinocerebellar Ataxia Type 2. Stereotact Funct Neurosurg. 2019; 97(4): 241243. DOI: 10.1159/000504062
  28. 28Velázquez-Pérez L, Medrano-Montero J, Rodríguez-Labrada R, et al. Cuban Hereditary Ataxias Network. Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients. Cerebellum. 2020 Apr; 19(2): 252264. DOI: 10.1007/s12311-020-01107-9
  29. 29Sasaki H, Wakisaka A, Sanpei K, et al. Phenotype variation correlates with CAG repeat length in SCA2–a study of 28 Japanese patients. J Neurol Sci. 1998 Aug 14; 159(2): 2028. DOI: 10.1016/s0022-510x(98)00166-x
  30. 30Sarva H, Severt WL, Jacoby N, Pullman SL, Saunders-Pullman R. Secondary orthostatic tremor in the setting of cerebellar degeneration. J Clin Neurosci. 2016 May; 27: 1735. DOI: 10.1016/j.jocn.2015.10.027
  31. 31Bonnet C, Apartis E, Anheim M, et al. Tremor-spectrum in spinocerebellar ataxia type 3. J Neurol. 2012 Nov; 259(11): 246070. DOI: 10.1007/s00415-012-6531-5
  32. 32Gan SR, Figueroa KP, Xu HL, et al. The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2020 Mar; 72: 3743. DOI: 10.1016/j.parkreldis.2020.02.004
  33. 33Lu CS, Chang HC, Kuo PC, et al. The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. Parkinsonism Relat Disord. 2004 Aug; 10(6): 36973. DOI: 10.1016/j.parkreldis.2004.03.009
  34. 34Ishida C, Sakajiri K, Yoshikawa H, et al. Lower limb tremor in Machado-Joseph disease. Neurology. 1998 Oct; 51(4): 12256. DOI: 10.1212/wnl.51.4.1225
  35. 35Shirai S, Yabe I, Naganuma R, et al. Tremor during orthostatism as the initial symptom of Machado-Joseph disease. Clin Neurol Neurosurg. 2018 Oct; 173: 173175. DOI: 10.1016/j.clineuro.2018.08.009
  36. 36Miura M, Numasawa Y, Takahisa M, et al. Levodopa-responsive truncal tremor in a patient with spinocerebellar ataxia type 3. J Neurol Sci. 2018 Sep 15; 392: 3233. DOI: 10.1016/j.jns.2018.06.023
  37. 37Juvonen V, Hietala M, Päivärinta M, et al. Clinical and genetic findings in Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol. 2000 Sep; 48(3): 35461. DOI: 10.1002/1531-8249(200009)48:3<;354::AID-ANA10>3.0.CO;2-A
  38. 38Wu YR, Lin HY, Chen CM, et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet. 2004 Mar; 65(3): 20914. DOI: 10.1111/j.0009-9163.2004.00213.x
  39. 39Samukawa M, Hirano M, Saigoh K, et al. PSP-Phenotype in SCA8: Case Report and Systemic Review. Cerebellum. 2019 Feb; 18(1): 7684. DOI: 10.1007/s12311-018-0955-0
  40. 40Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord. 2005 May; 11(3): 14750. DOI: 10.1016/j.parkreldis.2004.10.008
  41. 41Smetcoren C, Weckhuysen D. SCA 8 mimicking MSA-C. Acta Neurol Belg. 2016 Jun; 116(2): 2212. DOI: 10.1007/s13760-015-0523-z
  42. 42Zhou Y, Yuan Y, Liu Z, et al. Genetic and clinical analyses of spinocerebellar ataxia type 8 in mainland China. J Neurol. 2019 Dec; 266(12): 29792986. DOI: 10.1007/s00415-019-09519-2
  43. 43Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009 Nov; 15(9): 6216. DOI: 10.1016/j.parkreldis.2009.06.001
  44. 44Kumar N, Miller GM. White matter hyperintense lesions in genetically proven spinocerebellar ataxia 8. Clin Neurol Neurosurg. 2008 Jan; 110(1): 658. DOI: 10.1016/j.clineuro.2007.08.014
  45. 45Domingues BMD, Nascimento FA, Meira AT, et al. Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families. Cerebellum. 2019 Oct; 18(5): 849854. DOI: 10.1007/s12311-019-01064-y
  46. 46Bahl S, Virdi K, Mittal U, et al. Evidence of a common founder for SCA12 in the Indian population. Ann Hum Genet. 2005 Sep; 69(Pt 5): 52834. DOI: 10.1046/j.1529-8817.2005.00173.x
  47. 47Srivastava AK, Choudhry S, Gopinath MS, et al. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neurol. 2001 Dec; 50(6): 796800. DOI: 10.1002/ana.10048
  48. 48Srivastava AK, Takkar A, Garg A, Faruq M. Clinical behaviour of spinocerebellar ataxia type 12 and intermediate length abnormal CAG repeats in PPP2R2B. Brain. 2017 Jan; 140(1): 2736. DOI: 10.1093/brain/aww269
  49. 49Holmes SE, O’Hearn EE, McInnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5’ region of PPP2R2B is associated with SCA12. Nat Genet. 1999 Dec; 23(4): 3912. DOI: 10.1038/70493
  50. 50Holmes SE, Hearn EO, Ross CA, Margolis RL. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull. 2001 Oct–Nov 1; 56(3–4): 397403. DOI: 10.1016/s0361-9230(01)00596-2
  51. 51Ganaraja VH, Holla VV, Stezin A, et al. Clinical, Radiological, and Genetic Profile of Spinocerebellar Ataxia 12: A Hospital-Based Cohort Analysis. Tremor Other Hyperkinet Mov (N Y). 2022 Apr 21; 12: 13. DOI: 10.5334/tohm.686
  52. 52Brussino A, Graziano C, Giobbe D, et al. Spinocerebellar ataxia type 12 identified in two Italian families may mimic sporadic ataxia. Mov Disord. 2010 Jul 15; 25(9): 126973. DOI: 10.1002/mds.22835
  53. 53Choudhury S, Chatterjee S, Chatterjee K, et al. Clinical Characterization of Genetically Diagnosed Cases of Spinocerebellar Ataxia Type 12 from India. Mov Disord Clin Pract. 2017 Nov 1; 5(1): 3946. DOI: 10.1002/mdc3.12551
  54. 54Bhansali S, Choudhury S, Siddique U, Basu P, Kumar H. Asymmetry of Tremor in Spinocerebellar Ataxia 12- Exception or Rule? Mov Disord Clin Pract. 2021 May 25; 8(5): 809811. DOI: 10.1002/mdc3.13237
  55. 55Yao T, Qiao H, Sun J, et al. Clinical and Preclinical Neuroimaging Changes in Spinocerebellar Ataxia Type 12: A Study of Three Chinese Pedigrees. Eur Neurol. 2022; 85(6): 467477. DOI: 10.1159/000525272
  56. 56Rossi J, Cavallieri F, Giovannini G, et al. Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12. Neurogenetics. 2019 Aug; 20(3): 161164. DOI: 10.1007/s10048-019-00580-7
  57. 57Holla VV, Prasad S, Kamble N, Pal PK. Spinocerebellar Ataxia Type 12 with an Atypical Ethnicity: A Report of 2 Families. Ann Indian Acad Neurol. 2021 Jul–Aug; 24(4): 614616. DOI: 10.4103/aian.AIAN_930_20
  58. 58Ganos C, Saifee TA, Kassavetis P, et al. Dystonic Tremor and Spasmodic Dysphonia in Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2014 Apr 10; 1(1): 7981. DOI: 10.1002/mdc3.12006
  59. 59Kalia LV, Rockman-Greenberg C, Borys A, Lang AE. Tremor in Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2014 Apr 10; 1(1): 7678. DOI: 10.1002/mdc3.12015
  60. 60Bhattad S, Rawat CS, Pandey S. Monochorea of the Upper Limb in a Patient with Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2021 Sep 3; 8(Suppl 1): S51S52. DOI: 10.1002/mdc3.13288
  61. 61Lang AE, Bhattad S, Rawat CS, Pandey S, Sethi KD. Commentary: Monochorea of the Upper Limb in a Patient with Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2021 Sep 3; 8(Suppl 1): S53S54. DOI: 10.1002/mdc3.13290
  62. 62Vlak MH, Sinke RJ, Rabelink GM, Kremer BP, van de Warrenburg BP. Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord. 2006 Jul; 21(7): 10258. DOI: 10.1002/mds.20851
  63. 63Foncke EM, Beukers RJ, Tijssen CC, Koelman JH, Tijssen MA. Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. Parkinsonism Relat Disord. 2010 May; 16(4): 2889. DOI: 10.1016/j.parkreldis.2009.10.008
  64. 64Koht J, Stevanin G, Durr A, Mundwiller E, Brice A, Tallaksen CM. SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene. Acta Neurol Scand. 2012 Feb; 125(2): 11622. DOI: 10.1111/j.1600-0404.2011.01504.x
  65. 65Riso V, Rossi S, Perna A, Nicoletti T, Bosco L, Zanni G, Silvestri G. NGS-based detection of a novel mutation in PRKCG (SCA14) in sporadic adult-onset ataxia plus dystonic tremor. Neurol Sci. 2020 Oct; 41(10): 29892991. DOI: 10.1007/s10072-020-04443-0
  66. 66Klebe S, Durr A, Rentschler A, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov; 58(5): 7209. DOI: 10.1002/ana.20628
  67. 67Chelban V, Wiethoff S, Fabian-Jessing BK, et al. Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14. Mov Disord. 2018 Jul; 33(7): 11191129. DOI: 10.1002/mds.27334
  68. 68Rossi M, Hamed M, Rodríguez-Antigüedad J, et al. Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review. Mov Disord. 2023 Mar; 38(3): 368377. DOI: 10.1002/mds.29278
  69. 69Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet. 2001 Jul 1; 10(14): 14418. DOI: 10.1093/hmg/10.14.1441
  70. 70Nielsen TT, Mardosiene S, Løkkegaard A, et al. Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report. BMC Neurol. 2012 Aug 13; 12: 73. DOI: 10.1186/1471-2377-12-73
  71. 71Oyama G, Thompson A, Foote KD, et al. Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y). 2014 Jul 9; 4: 228. DOI: 10.5334/tohm.180
  72. 72Echeveste B, Covarrubias E, Cabello JP, Luquin MR. Isolated palatal tremor as unique clinical manifestation of SCA 18 due to a new mutation of IFRD1. Parkinsonism Relat Disord. 2017 Sep; 42: 100101. DOI: 10.1016/j.parkreldis.2017.05.026
  73. 73Schelhaas HJ, Ippel PF, Hageman G, Sinke RJ, van der Laan EN, Beemer FA. Clinical and genetic analysis of a four-generation family with a distinct autosomal dominant cerebellar ataxia. J Neurol. 2001 Feb; 248(2): 11320. DOI: 10.1007/s004150170245
  74. 74Palombo F, La Morgia C, Fiorini C, et al. A Second Case With the V374 A KCND3 Pathogenic Variant in an Italian Patient With Early-Onset Spinocerebellar Ataxia. Neurol Genet. 2022 Aug 8; 8(5):e200004. DOI: 10.1212/NXG.0000000000200004
  75. 75Storey E, Gardner RJ. Spinocerebellar ataxia type 20. Handb Clin Neurol. 2012; 103: 56773. DOI: 10.1016/B978-0-444-51892-7.00038-3
  76. 76Knight MA, Gardner RJ, Bahlo M, et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain. 2004 May; 127(Pt 5): 117281. DOI: 10.1093/brain/awh139
  77. 77Vuillaume I, Devos D, Schraen-Maschke S, et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol. 2002 Nov; 52(5): 66670. DOI: 10.1002/ana.10344
  78. 78Riso V, Galatolo D, Barghigiani M, et al. A next generation sequencing-based analysis of a large cohort of ataxic patients refines the clinical spectrum associated with spinocerebellar ataxia 21. Eur J Neurol. 2021 Aug; 28(8): 27842788. DOI: 10.1111/ene.14868
  79. 79Traschütz A, van Gaalen J, Oosterloo M, et al. The movement disorder spectrum of SCA21 (ATX-TMEM240): 3 novel families and systematic review of the literature. Parkinsonism Relat Disord. 2019 May; 62: 215220. DOI: 10.1016/j.parkreldis.2018.11.027
  80. 80Zeng S, Zeng J, He M, et al. Spinocerebellar ataxia type 21 exists in the Chinese Han population. Sci Rep. 2016 Jan 27; 6: 19897. DOI: 10.1038/srep19897
  81. 81Camargo CHF, Piva-Silva AKC, Munhoz RP, Raskin S, Teive HAG. Spinocerebellar ataxia type 21 (TMEM240) with tremor and dystonia. Eur J Neurol. 2021 Aug; 28(8): e63e64. DOI: 10.1111/ene.14944
  82. 82van Swieten JC, Brusse E, de Graaf BM, et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet. 2003 Jan; 72(1): 1919. DOI: 10.1086/345488
  83. 83Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC. Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype. Mov Disord. 2006 Mar; 21(3): 396401. DOI: 10.1002/mds.20708
  84. 84Coebergh JA, Fransen van de Putte DE, Snoeck IN, Ruivenkamp C, van Haeringen A, Smit LM. A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene. Eur J Paediatr Neurol. 2014 May; 18(3): 4135. DOI: 10.1016/j.ejpn.2013.10.006
  85. 85Groth CL, Berman BD. Spinocerebellar Ataxia 27: A Review and Characterization of an Evolving Phenotype. Tremor Other Hyperkinet Mov (N Y). 2018 Jan 30; 8: 534. DOI: 10.5334/tohm.436
  86. 86Paucar M, Lundin J, Alshammari T, et al. Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27. J Intern Med. 2020 Jul; 288(1): 103115. DOI: 10.1111/joim.13052
  87. 87Piarroux J, Riant F, Humbertclaude V, et al. FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9. Ann Clin Transl Neurol. 2020 Apr; 7(4): 565572. DOI: 10.1002/acn3.51005
  88. 88Pellerin D, Danzi MC, Wilke C, et al. Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia. N Engl J Med. 2023 Jan 12; 388(2): 128141. DOI: 10.1056/NEJMoa2207406
  89. 89Rafehi H, Read J, Szmulewicz DJ, et al. An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA27B/ATX-FGF14. Am J Hum Genet. 2023 Jun 1; 110(6): 1018. DOI: 10.1016/j.ajhg.2023.05.005
  90. 90Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 193003: 10/11/2022: World Wide Web URL: https://omim.org/.
  91. 91Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 620174: 01/18/2023: World Wide Web URL: https://omim.org/.
  92. 92Zambonin JL, Bellomo A, Ben-Pazi H, et al; Care4Rare Canada Consortium; Dudding-Byth T, Boycott KM. Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxia. Orphanet J Rare Dis. 2017 Jun 28; 12(1): 121. DOI: 10.1186/s13023-017-0672-7
  93. 93Wang L, Hao Y, Yu P, et al. Identification of a Splicing Mutation in ITPR1 via WES in a Chinese Early-Onset Spinocerebellar Ataxia Family. Cerebellum. 2018 Jun; 17(3): 294299. DOI: 10.1007/s12311-017-0896-z
  94. 94Ngo KJ, Poke G, Neas K, Fogel BL. Spinocerebellar Ataxia type 29 in a family of Māori descent. Cerebellum Ataxias. 2019 Oct 12; 6: 14. DOI: 10.1186/s40673-019-0108-3
  95. 95Guo YC, Lin JJ, Liao YC, Tsai PC, Lee YC, Soong BW. Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization. Neurology. 2014 Oct 21; 83(17): 155461. DOI: 10.1212/WNL.0000000000000909
  96. 96Wang JL, Yang X, Xia K, et al. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain. 2010 Dec; 133(Pt 12): 35108. DOI: 10.1093/brain/awq323
  97. 97Fasano A, Hodaie M, Munhoz RP, Rohani M. SCA 35 presenting as isolated treatment-resistant dystonic hand tremor. Parkinsonism Relat Disord. 2017 Apr; 37: 118119. DOI: 10.1016/j.parkreldis.2017.01.014
  98. 98Obayashi M, Stevanin G, Synofzik M, et al. Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion. J Neurol Neurosurg Psychiatry. 2015 Sep; 86(9): 98695. DOI: 10.1136/jnnp-2014-309153
  99. 99Emamikhah M, Aghavali S, Moghadas F, et al. Spinocerebellar Ataxia 40: Another Etiology Underlying Essential Tremor Syndrome. Mov Disord Clin Pract. 2021 May 25; 8(6): 944946. DOI: 10.1002/mdc3.13251
  100. 100Tsoi H, Yu AC, Chen ZS, et al. A novel missense mutation in CCDC88C activates the JNK pathway and causes a dominant form of spinocerebellar ataxia. J Med Genet. 2014 Sep; 51(9): 5905. DOI: 10.1136/jmedgenet-2014-102333
  101. 101Boros FA, Szpisjak L, Bozó R, et al. Spinocerebellar Ataxia in a Hungarian Female Patient with a Novel Variant of Unknown Significance in the CCDC88C Gene. Int J Mol Sci. 2023 Jan 30; 24(3): 2617. DOI: 10.3390/ijms24032617
  102. 102Han F, Su D, Qu C. Spinocerebellar ataxia type 40: A case report and literature review. Transl Neurosci. 2021 Oct 18; 12(1): 379384. DOI: 10.1515/tnsci-2020-0190
  103. 103Leńska-Mieciek M, Charzewska A, Królicki L, et al. Familial ataxia, tremor, and dementia in a polish family with a novel mutation in the CCDC88C gene. Mov Disord. 2019 Jan; 34(1): 142144. DOI: 10.1002/mds.27536
  104. 104Hara N, Nezu T, Kobatake K, Morino H, Kawakami H, Maruyama H. Treatment of intractable resting tremor of spinocerebellar ataxia 42 with zonisamide. J Neurol Sci. 2019 Jan 15; 396: 119120. DOI: 10.1016/j.jns.2018.11.013
  105. 105Ngo K, Aker M, Petty LE, et al. Expanding the global prevalence of spinocerebellar ataxia type 42. Neurol Genet. 2018 Apr 5; 4(3): e232. DOI: 10.1212/NXG.0000000000000232
  106. 106Coutelier M, Blesneac I, Monteil A, et al. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. Am J Hum Genet. 2015 Nov 5; 97(5): 72637. DOI: 10.1016/j.ajhg.2015.09.007
  107. 107Morino H, Matsuda Y, Muguruma K, et al. A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia. Mol Brain. 2015 Dec 29; 8: 89. DOI: 10.1186/s13041-015-0180-4
  108. 108De Michele G, Lieto M, Galatolo D, et al. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families. Parkinsonism Relat Disord. 2019 Aug; 65: 9196. DOI: 10.1016/j.parkreldis.2019.05.001
  109. 109Lieto M, Riso V, Galatolo D, et al. The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families. Eur J Neurol. 2020 Mar; 27(3): 498505. DOI: 10.1111/ene.14094
  110. 110Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 620158: 03/13/2023: World Wide Web URL: https://omim.org/.
  111. 111Coutelier M, Jacoupy M, Janer A, et al. NPTX1 mutations trigger endoplasmic reticulum stress and cause autosomal dominant cerebellar ataxia. Brain. 2022 May 24; 145(4): 15191534. DOI: 10.1093/brain/awab407
  112. 112Velázquez-Pérez L, Cerecedo-Zapata CM, Hernández-Hernández O, et al. A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7. Neurogenetics. 2015 Jan; 16(1): 1121. DOI: 10.1007/s10048-014-0424-y
  113. 113Salas-Vargas J, Mancera-Gervacio J, Velázquez-Pérez L, et al. Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy. Eur Neurol. 2015; 73(3–4): 1738. DOI: 10.1159/000370239
  114. 114David G, Dürr A, Stevanin G, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet. 1998 Feb; 7(2): 16570. DOI: 10.1093/hmg/7.2.165
  115. 115Gu W, Wang Y, Liu X, Zhou B, Zhou Y, Wang G. Molecular and clinical study of spinocerebellar ataxia type 7 in Chinese kindreds. Arch Neurol. 2000 Oct; 57(10): 15138. DOI: 10.1001/archneur.57.10.1513
  116. 116Modi G, Modi M, Martinus I, Rodda J, Saffer D. The clinical and genetic characteristics of spinocerebellar ataxia type 7 (SCA 7) in three Black South African families. Acta Neurol Scand. 2000 Mar; 101(3): 17782. DOI: 10.1034/j.1600-0404.2000.101003177.x
  117. 117Bürk K, Zühlke C, König IR, et al. Spinocerebellar ataxia type 5: clinical and molecular genetic features of a German kindred. Neurology. 2004 Jan 27; 62(2): 3279. DOI: 10.1212/01.wnl.0000103293.63340.c1
  118. 118Mizuno T, Kashimada A, Nomura T, et al. Infantile-onset spinocerebellar ataxia type 5 associated with a novel SPTBN2 mutation: A case report. Brain Dev. 2019 Aug; 41(7): 630633. DOI: 10.1016/j.braindev.2019.03.002
  119. 119Jacob FD, Ho ES, Martinez-Ojeda M, Darras BT, Khwaja OS. Case of infantile onset spinocerebellar ataxia type 5. J Child Neurol. 2013 Oct; 28(10): 12925. DOI: 10.1177/0883073812454331
  120. 120Watanabe H, Tanaka F, Matsumoto M, et al. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6. Clin Genet. 1998 Jan; 53(1): 139. DOI: 10.1034/j.1399-0004.1998.531530104.x
  121. 121Nishida T, Nakajima M. A refractory head tremor appearing after volatile anesthesia combined with epidural anesthesia in a patient with spinocerebellar ataxia type 6. JA Clin Rep. 2018 Jan 30; 4(1): 13. DOI: 10.1186/s40981-018-0150-9
  122. 122Hara K, Fukushima T, Suzuki T, et al. Japanese SCA families with an unusual phenotype linked to a locus overlapping with SCA15 locus. Neurology. 2004 Feb 24; 62(4): 64851. DOI: 10.1212/01.wnl.0000110190.08412.25
  123. 123Marelli C, van de Leemput J, Johnson JO, et al. SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia. Arch Neurol. 2011 May; 68(5): 63743. DOI: 10.1001/archneurol.2011.81
  124. 124Tipton PW, Guthrie K, Strongosky A, Reimer R, Wszolek ZK. Spinocerebellar ataxia 15: A phenotypic review and expansion. Neurol Neurochir Pol. 2017 Jan–Feb; 51(1): 8691. DOI: 10.1016/j.pjnns.2016.10.006
  125. 125Miyoshi Y, Yamada T, Tanimura M, et al. A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1. Neurology. 2001 Jul 10; 57(1): 96100. DOI: 10.1212/wnl.57.1.96
  126. 126Storey E, Gardner RJ. Spinocerebellar ataxia type 15. Handb Clin Neurol. 2012; 103: 5615. DOI: 10.1016/B978-0-444-51892-7.00037-1
  127. 127Sasaki M, Ohba C, Iai M, et al. Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 gene. J Neurol. 2015 May; 262(5): 127884. DOI: 10.1007/s00415-015-7705-8
  128. 128Wu F, Wang X, Li X, Teng H, Tian T, Bai J. Spinocerebellar ataxia type 23 (SCA23): a review. J Neurol. 2021 Dec; 268(12): 46304645. DOI: 10.1007/s00415-020-10297-5
  129. 129Saigoh K, Mitsui J, Hirano M, et al. The first Japanese familial case of spinocerebellar ataxia 23 with a novel mutation in the PDYN gene. Parkinsonism Relat Disord. 2015 Mar; 21(3): 3324. DOI: 10.1016/j.parkreldis.2014.12.028
  130. 130Bakalkin G, Watanabe H, Jezierska J, et al. Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. Am J Hum Genet. 2010 Nov 12; 87(5): 593603. DOI: 10.1016/j.ajhg.2010.10.001
  131. 131Satoh S, Kondo Y, Ohara S, Yamaguchi T, Nakamura K, Yoshida K. Intrafamilial phenotypic variation in spinocerebellar ataxia type 23. Cerebellum Ataxias. 2020 Jun 23; 7: 7. DOI: 10.1186/s40673-020-00117-x
  132. 132Saucier J, Al-Qadi M, Amor MB, Ishikawa K, Chamard-Witkowski L. Spinocerebellar ataxia type 31: A clinical and radiological literature review. J Neurol Sci. 2023 Jan 15; 444: 120527. DOI: 10.1016/j.jns.2022.120527
  133. 133Norioka R, Sugaya K, Murayama A, et al. Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction. Cerebellum Ataxias. 2021 Mar 30; 8(1): 11. DOI: 10.1186/s40673-021-00134-4
  134. 134Corral-Juan M, Serrano-Munuera C, Rábano A, et al. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37. Brain. 2018 Jul 1; 141(7): 19811997. DOI: 10.1093/brain/awy137
  135. 135Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012; 124: 121. DOI: 10.1007/s00401-012-1000-x
  136. 136Meira AT, Arruda WO, Ono SE, et al. Neuroradiological Findings in the Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2019 Sep 26; 9. DOI: 10.5334/tohm.516
  137. 137Hashimoto T, Muralidharan A, Yoshida K, et al. Neuronal activity and outcomes from thalamic surgery for spinocerebellar ataxia. Ann Clin Transl Neurol. 2017 Dec 10; 5(1): 5263. DOI: 10.1002/acn3.508
  138. 138Purrer V, Upadhyay N, Pieper CC, et al. Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Spinocerebellar Ataxia Type 12. Mov Disord. 2022 Apr; 37(4): 872873. DOI: 10.1002/mds.28918
  139. 139Cury RG, França C, Duarte KP, et al. Safety and Outcomes of Dentate Nucleus Deep Brain Stimulation for Cerebellar Ataxia. Cerebellum. 2022 Oct; 21(5): 861865. DOI: 10.1007/s12311-021-01326-8
  140. 140Mascalchi M, Vella A. Neuroimaging Applications in Chronic Ataxias. Int Rev Neurobiol. 2018; 143: 109162. DOI: 10.1016/bs.irn.2018.09.011
  141. 141Hallett M. Parkinson’s disease tremor: pathophysiology. Parkinsonism Relat Disord. 2012 Jan; 18(Suppl 1): S856. DOI: 10.1016/S1353-8020(11)70027-X
  142. 142Latorre A, Del Gamba C, Menozzi E, Balint B, Brugger F, Bhatia KP. Abnormal DaTSCAN and Atypical Parkinsonism in SCA12. Mov Disord Clin Pract. 2019 Mar 28; 6(5): 400402. DOI: 10.1002/mdc3.12751
  143. 143DeSimone JC, Archer DB, Vaillancourt DE, Wagle Shukla A. Network-level connectivity is a critical feature distinguishing dystonic tremor and essential tremor. Brain. 2019 Jun 1; 142(6): 16441659. DOI: 10.1093/brain/awz085
  144. 144Nieuwhof F, Toni I, Dirkx MF, et al. Cerebello-thalamic activity drives an abnormal motor network into dystonic tremor. Neuroimage Clin. 2022; 33: 102919. DOI: 10.1016/j.nicl.2021.102919
  145. 145Panyakaew P, Cho HJ, Lee SW, Wu T, Hallett M. The Pathophysiology of Dystonic Tremors and Comparison With Essential Tremor. J Neurosci. 2020 Nov 25; 40(48): 93179326. DOI: 10.1523/JNEUROSCI.1181-20.2020
  146. 146Caligiore D, Pezzulo G, Baldassarre G, et al. Consensus Paper: Towards a Systems-Level View of Cerebellar Function: the Interplay Between Cerebellum, Basal Ganglia, and Cortex. Cerebellum. 2017 Feb; 16(1): 203229. DOI: 10.1007/s12311-016-0763-3
  147. 147O’Hearn EE, Hwang HS, Holmes SE, et al. Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12. Mov Disord. 2015 Nov; 30(13): 18131824. DOI: 10.1002/mds.26348
  148. 148Kumar D, Srivastava AK, Faruq M, Gundluru VR. Spinocerebellar ataxia type 12: An update. Annals of Movement Disorders. 2019; 2(2): 4857. DOI: 10.4103/AOMD.AOMD_5_19
  149. 149O’Hearn E, Holmes SE, Margolis RL. Spinocerebellar ataxia type 12. Handb Clin Neurol. 2012; 103: 53547. DOI: 10.1016/B978-0-444-51892-7.00034-6
  150. 150Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol. 2004 Jan; 61(1): 358. DOI: 10.1001/archneur.61.1.35
  151. 151Simon-Sanchez J, Hanson M, Singleton A, et al. Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson’s disease. Neurosci Lett. 2005 Jul 1–8; 382(1–2): 1914. DOI: 10.1016/j.neulet.2005.03.015
  152. 152Socal MP, Emmel VE, Rieder CR, Hilbig A, Saraiva-Pereira ML, Jardim LB. Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions. Parkinsonism Relat Disord. 2009 Jun; 15(5): 3748. DOI: 10.1016/j.parkreldis.2008.09.005
  153. 153Boesch SM, Donnemiller E, Müller J, et al. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study. Mov Disord. 2004 Nov; 19(11): 13205. DOI: 10.1002/mds.20159
  154. 154Horimoto Y, Hayashi E, Ito Y, et al. Dopaminergic function in spinocerebellar ataxia type 6 patients with and without parkinsonism. J Neurol. 2020 Sep; 267(9): 26922696. DOI: 10.1007/s00415-020-09908-y
  155. 155Hara N, Morino H, Matsuda Y, et al. Zonisamide can ameliorate the voltage-dependence alteration of the T-type calcium channel CaV3.1 caused by a mutation responsible for spinocerebellar ataxia. Mol Brain. 2020 Nov 26; 13(1): 163. DOI: 10.1186/s13041-020-00700-7
  156. 156Matthews LG, Puryear CB, Correia SS, et al. T-type calcium channels as therapeutic targets in essential tremor and Parkinson’s disease. Ann Clin Transl Neurol. 2023 Apr; 10(4): 462483. DOI: 10.1002/acn3.51735
  157. 157Freund HJ, Barnikol UB, Nolte D, et al. Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor-A unusual clinical benefit. Mov Disord. 2007 Apr 15; 22(5): 7325. DOI: 10.1002/mds.21338
  158. 158Kuo MC, Tai CH, Tseng SH, Wu RM. Long-term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: A rare case report. Eur J Neurol. 2022 Aug; 29(8): 25442547. DOI: 10.1111/ene.15339
  159. 159Chiu SY, Nozile-Firth K, Klassen BT, et al. Ataxia and tolerance after thalamic deep brain stimulation for essential tremor. Parkinsonism Relat Disord. 2020 Nov; 80: 4753. DOI: 10.1016/j.parkreldis.2020.09.009
  160. 160Reich MM, Brumberg J, Pozzi NG, et al. Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy? Brain. 2016 Nov 1; 139(11): 29482956. DOI: 10.1093/brain/aww223
  161. 161Elias WJ, Lipsman N, Ondo WG, et al. A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. N Engl J Med. 2016 Aug 25; 375(8): 7309. DOI: 10.1056/NEJMoa1600159
  162. 162Bond AE, Shah BB, Huss DS, et al. Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017 Dec 1; 74(12): 14121418. DOI: 10.1001/jamaneurol.2017.3098
DOI: https://doi.org/10.5334/tohm.911 | Journal eISSN: 2160-8288
Language: English
Submitted on: Apr 29, 2024
Accepted on: Jun 14, 2024
Published on: Jun 20, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Adreesh Mukherjee, Sanjay Pandey, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.